MOA Illustrations of drugs in cancer immunotherapy.

Illustrations of the behavior of the protein LAG-3 (Lymphocyte-activation gene 3) and the mode of action of its soluble variant Eftilagimod Alpha (IMP321).

Content:  2 illustrations

Utilization: llustration Online, Print, PowerPoint

Specifications: 3000*2000 Pixel

Client: Immutep GmbH

The rights of use of the illustrations shown are with the respective clients.

 

 

LAG3 protein immunantwort

Effect of the protein LAG-3 (lymphocyte-activation gene 3) in the immune system